nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CA2—stomach cancer	0.276	0.628	CbGaD
Celecoxib—PTGS2—stomach cancer	0.0865	0.197	CbGaD
Celecoxib—ALB—stomach cancer	0.0771	0.175	CbGaD
Celecoxib—ABCC4—Fluorouracil—stomach cancer	0.0549	0.292	CbGbCtD
Celecoxib—ABCC4—Methotrexate—stomach cancer	0.0303	0.161	CbGbCtD
Celecoxib—ALB—Irinotecan—stomach cancer	0.0212	0.113	CbGbCtD
Celecoxib—ALB—Fluorouracil—stomach cancer	0.0203	0.108	CbGbCtD
Celecoxib—CYP2C9—Capecitabine—stomach cancer	0.0185	0.0983	CbGbCtD
Celecoxib—ALB—Methotrexate—stomach cancer	0.0112	0.0596	CbGbCtD
Celecoxib—CYP2C9—Fluorouracil—stomach cancer	0.011	0.0583	CbGbCtD
Celecoxib—CYP3A4—Irinotecan—stomach cancer	0.00665	0.0353	CbGbCtD
Celecoxib—CYP2D6—Doxorubicin—stomach cancer	0.00571	0.0303	CbGbCtD
Celecoxib—ORM1—bile—stomach cancer	0.00525	0.0863	CbGeAlD
Celecoxib—CYP3A4—Docetaxel—stomach cancer	0.00487	0.0259	CbGbCtD
Celecoxib—CYP3A4—Doxorubicin—stomach cancer	0.00363	0.0193	CbGbCtD
Celecoxib—MAPK14—blood vessel—stomach cancer	0.00257	0.0423	CbGeAlD
Celecoxib—PDPK1—hematopoietic system—stomach cancer	0.00256	0.0421	CbGeAlD
Celecoxib—CA9—gall bladder—stomach cancer	0.00248	0.0408	CbGeAlD
Celecoxib—PDPK1—lymphoid tissue—stomach cancer	0.0018	0.0296	CbGeAlD
Celecoxib—PDPK1—digestive system—stomach cancer	0.00178	0.0293	CbGeAlD
Celecoxib—PDPK1—endocrine gland—stomach cancer	0.00147	0.0242	CbGeAlD
Celecoxib—ORM1—gall bladder—stomach cancer	0.00146	0.024	CbGeAlD
Celecoxib—CA5A—endocrine gland—stomach cancer	0.00138	0.0227	CbGeAlD
Celecoxib—MAPK14—hematopoietic system—stomach cancer	0.00137	0.0225	CbGeAlD
Celecoxib—PDPK1—liver—stomach cancer	0.00133	0.0218	CbGeAlD
Celecoxib—ALB—gall bladder—stomach cancer	0.00128	0.021	CbGeAlD
Celecoxib—MAPK14—epithelium—stomach cancer	0.00125	0.0206	CbGeAlD
Celecoxib—CA5A—liver—stomach cancer	0.00125	0.0205	CbGeAlD
Celecoxib—MAPK14—smooth muscle tissue—stomach cancer	0.00121	0.0198	CbGeAlD
Celecoxib—PDPK1—lymph node—stomach cancer	0.00102	0.0167	CbGeAlD
Celecoxib—CA9—digestive system—stomach cancer	0.000978	0.0161	CbGeAlD
Celecoxib—MAPK14—lymphoid tissue—stomach cancer	0.000965	0.0159	CbGeAlD
Celecoxib—MAPK14—digestive system—stomach cancer	0.000953	0.0157	CbGeAlD
Celecoxib—CA2—gall bladder—stomach cancer	0.000943	0.0155	CbGeAlD
Celecoxib—CA5B—hematopoietic system—stomach cancer	0.000933	0.0153	CbGeAlD
Celecoxib—MAPK14—bone marrow—stomach cancer	0.000879	0.0144	CbGeAlD
Celecoxib—ORM1—hematopoietic system—stomach cancer	0.000825	0.0136	CbGeAlD
Celecoxib—CA9—endocrine gland—stomach cancer	0.000808	0.0133	CbGeAlD
Celecoxib—MAPK14—endocrine gland—stomach cancer	0.000788	0.0129	CbGeAlD
Celecoxib—Sulfaphenazole—CYP2A6—stomach cancer	0.000771	0.568	CrCbGaD
Celecoxib—CA5B—pancreas—stomach cancer	0.00076	0.0125	CbGeAlD
Celecoxib—PTGS2—blood vessel—stomach cancer	0.00074	0.0122	CbGeAlD
Celecoxib—CA12—digestive system—stomach cancer	0.000723	0.0119	CbGeAlD
Celecoxib—MAPK14—liver—stomach cancer	0.00071	0.0117	CbGeAlD
Celecoxib—ABCC4—hematopoietic system—stomach cancer	0.0007	0.0115	CbGeAlD
Celecoxib—PTGS2—gall bladder—stomach cancer	0.000697	0.0114	CbGeAlD
Celecoxib—CA14—liver—stomach cancer	0.000691	0.0113	CbGeAlD
Celecoxib—CA12—endocrine gland—stomach cancer	0.000598	0.00982	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—stomach cancer	0.000585	0.432	CrCbGaD
Celecoxib—ABCC4—pancreas—stomach cancer	0.00057	0.00937	CbGeAlD
Celecoxib—MAPK14—lymph node—stomach cancer	0.000545	0.00895	CbGeAlD
Celecoxib—CA5B—endocrine gland—stomach cancer	0.000536	0.00881	CbGeAlD
Celecoxib—CA2—hematopoietic system—stomach cancer	0.000534	0.00877	CbGeAlD
Celecoxib—ORM1—bone marrow—stomach cancer	0.000529	0.00869	CbGeAlD
Celecoxib—CA2—epithelium—stomach cancer	0.000488	0.00802	CbGeAlD
Celecoxib—ABCC4—digestive system—stomach cancer	0.000487	0.008	CbGeAlD
Celecoxib—ORM1—endocrine gland—stomach cancer	0.000474	0.00779	CbGeAlD
Celecoxib—CA2—smooth muscle tissue—stomach cancer	0.00047	0.00773	CbGeAlD
Celecoxib—CYP2C9—hematopoietic system—stomach cancer	0.000452	0.00742	CbGeAlD
Celecoxib—ABCC4—bone marrow—stomach cancer	0.000449	0.00738	CbGeAlD
Celecoxib—CA4—digestive system—stomach cancer	0.000448	0.00736	CbGeAlD
Celecoxib—CA2—pancreas—stomach cancer	0.000435	0.00714	CbGeAlD
Celecoxib—ORM1—liver—stomach cancer	0.000428	0.00702	CbGeAlD
Celecoxib—CA4—bone marrow—stomach cancer	0.000413	0.00678	CbGeAlD
Celecoxib—ABCC4—endocrine gland—stomach cancer	0.000403	0.00661	CbGeAlD
Celecoxib—PTGS2—hematopoietic system—stomach cancer	0.000394	0.00648	CbGeAlD
Celecoxib—CA2—lymphoid tissue—stomach cancer	0.000376	0.00618	CbGeAlD
Celecoxib—ALB—liver—stomach cancer	0.000375	0.00616	CbGeAlD
Celecoxib—CA2—digestive system—stomach cancer	0.000371	0.0061	CbGeAlD
Celecoxib—CA5B—lymph node—stomach cancer	0.000371	0.00609	CbGeAlD
Celecoxib—CA4—endocrine gland—stomach cancer	0.00037	0.00608	CbGeAlD
Celecoxib—ABCC4—liver—stomach cancer	0.000363	0.00596	CbGeAlD
Celecoxib—PTGS2—epithelium—stomach cancer	0.00036	0.00592	CbGeAlD
Celecoxib—PTGS2—smooth muscle tissue—stomach cancer	0.000347	0.0057	CbGeAlD
Celecoxib—CYP3A4—hematopoietic system—stomach cancer	0.000344	0.00566	CbGeAlD
Celecoxib—CA2—bone marrow—stomach cancer	0.000342	0.00562	CbGeAlD
Celecoxib—CYP2D6—hematopoietic system—stomach cancer	0.000339	0.00557	CbGeAlD
Celecoxib—ORM1—lymph node—stomach cancer	0.000328	0.00539	CbGeAlD
Celecoxib—PTGS2—pancreas—stomach cancer	0.000321	0.00527	CbGeAlD
Celecoxib—CYP2C9—digestive system—stomach cancer	0.000314	0.00516	CbGeAlD
Celecoxib—CA2—endocrine gland—stomach cancer	0.000307	0.00504	CbGeAlD
Celecoxib—ALB—lymph node—stomach cancer	0.000287	0.00472	CbGeAlD
Celecoxib—ABCC4—lymph node—stomach cancer	0.000278	0.00457	CbGeAlD
Celecoxib—PTGS2—lymphoid tissue—stomach cancer	0.000278	0.00456	CbGeAlD
Celecoxib—CA2—liver—stomach cancer	0.000277	0.00454	CbGeAlD
Celecoxib—PTGS2—digestive system—stomach cancer	0.000274	0.0045	CbGeAlD
Celecoxib—CYP2C9—endocrine gland—stomach cancer	0.00026	0.00426	CbGeAlD
Celecoxib—CA4—lymph node—stomach cancer	0.000256	0.0042	CbGeAlD
Celecoxib—PTGS2—bone marrow—stomach cancer	0.000253	0.00415	CbGeAlD
Celecoxib—CYP3A4—digestive system—stomach cancer	0.00024	0.00394	CbGeAlD
Celecoxib—CYP2D6—digestive system—stomach cancer	0.000236	0.00387	CbGeAlD
Celecoxib—CYP2C9—liver—stomach cancer	0.000234	0.00384	CbGeAlD
Celecoxib—PTGS2—endocrine gland—stomach cancer	0.000227	0.00372	CbGeAlD
Celecoxib—CA2—lymph node—stomach cancer	0.000212	0.00348	CbGeAlD
Celecoxib—PTGS2—liver—stomach cancer	0.000204	0.00336	CbGeAlD
Celecoxib—CYP3A4—endocrine gland—stomach cancer	0.000198	0.00325	CbGeAlD
Celecoxib—CYP2D6—endocrine gland—stomach cancer	0.000195	0.0032	CbGeAlD
Celecoxib—CYP3A4—liver—stomach cancer	0.000178	0.00293	CbGeAlD
Celecoxib—CYP2D6—liver—stomach cancer	0.000176	0.00289	CbGeAlD
Celecoxib—PTGS2—lymph node—stomach cancer	0.000157	0.00257	CbGeAlD
Celecoxib—Mediastinal disorder—Methotrexate—stomach cancer	6.44e-05	0.000431	CcSEcCtD
Celecoxib—Agranulocytosis—Doxorubicin—stomach cancer	6.44e-05	0.00043	CcSEcCtD
Celecoxib—Rash—Irinotecan—stomach cancer	6.43e-05	0.00043	CcSEcCtD
Celecoxib—Dermatitis—Irinotecan—stomach cancer	6.42e-05	0.000429	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Docetaxel—stomach cancer	6.42e-05	0.000429	CcSEcCtD
Celecoxib—Headache—Irinotecan—stomach cancer	6.39e-05	0.000427	CcSEcCtD
Celecoxib—Insomnia—Docetaxel—stomach cancer	6.37e-05	0.000426	CcSEcCtD
Celecoxib—Paraesthesia—Docetaxel—stomach cancer	6.33e-05	0.000423	CcSEcCtD
Celecoxib—Erythema multiforme—Epirubicin—stomach cancer	6.33e-05	0.000423	CcSEcCtD
Celecoxib—Alopecia—Methotrexate—stomach cancer	6.32e-05	0.000422	CcSEcCtD
Celecoxib—Dyspnoea—Docetaxel—stomach cancer	6.28e-05	0.00042	CcSEcCtD
Celecoxib—Somnolence—Docetaxel—stomach cancer	6.27e-05	0.000419	CcSEcCtD
Celecoxib—Mental disorder—Methotrexate—stomach cancer	6.26e-05	0.000419	CcSEcCtD
Celecoxib—Eye disorder—Epirubicin—stomach cancer	6.25e-05	0.000418	CcSEcCtD
Celecoxib—Tinnitus—Epirubicin—stomach cancer	6.24e-05	0.000417	CcSEcCtD
Celecoxib—Haemoglobin—Doxorubicin—stomach cancer	6.22e-05	0.000416	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Capecitabine—stomach cancer	6.22e-05	0.000416	CcSEcCtD
Celecoxib—Flushing—Epirubicin—stomach cancer	6.21e-05	0.000415	CcSEcCtD
Celecoxib—Cardiac disorder—Epirubicin—stomach cancer	6.21e-05	0.000415	CcSEcCtD
Celecoxib—Vomiting—Fluorouracil—stomach cancer	6.21e-05	0.000415	CcSEcCtD
Celecoxib—Rhinitis—Doxorubicin—stomach cancer	6.21e-05	0.000415	CcSEcCtD
Celecoxib—Dyspepsia—Docetaxel—stomach cancer	6.2e-05	0.000415	CcSEcCtD
Celecoxib—Haemorrhage—Doxorubicin—stomach cancer	6.19e-05	0.000414	CcSEcCtD
Celecoxib—Hepatitis—Doxorubicin—stomach cancer	6.19e-05	0.000414	CcSEcCtD
Celecoxib—Insomnia—Capecitabine—stomach cancer	6.17e-05	0.000413	CcSEcCtD
Celecoxib—Hypoaesthesia—Doxorubicin—stomach cancer	6.16e-05	0.000412	CcSEcCtD
Celecoxib—Rash—Fluorouracil—stomach cancer	6.16e-05	0.000412	CcSEcCtD
Celecoxib—Dermatitis—Fluorouracil—stomach cancer	6.15e-05	0.000411	CcSEcCtD
Celecoxib—Pharyngitis—Doxorubicin—stomach cancer	6.14e-05	0.000411	CcSEcCtD
Celecoxib—Paraesthesia—Capecitabine—stomach cancer	6.13e-05	0.00041	CcSEcCtD
Celecoxib—Decreased appetite—Docetaxel—stomach cancer	6.13e-05	0.00041	CcSEcCtD
Celecoxib—Headache—Fluorouracil—stomach cancer	6.12e-05	0.000409	CcSEcCtD
Celecoxib—Urinary tract disorder—Doxorubicin—stomach cancer	6.11e-05	0.000409	CcSEcCtD
Celecoxib—Oedema peripheral—Doxorubicin—stomach cancer	6.1e-05	0.000408	CcSEcCtD
Celecoxib—Dysgeusia—Methotrexate—stomach cancer	6.09e-05	0.000407	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Docetaxel—stomach cancer	6.08e-05	0.000407	CcSEcCtD
Celecoxib—Connective tissue disorder—Doxorubicin—stomach cancer	6.08e-05	0.000407	CcSEcCtD
Celecoxib—Dyspnoea—Capecitabine—stomach cancer	6.08e-05	0.000407	CcSEcCtD
Celecoxib—Fatigue—Docetaxel—stomach cancer	6.08e-05	0.000406	CcSEcCtD
Celecoxib—Angiopathy—Epirubicin—stomach cancer	6.07e-05	0.000406	CcSEcCtD
Celecoxib—Urethral disorder—Doxorubicin—stomach cancer	6.07e-05	0.000406	CcSEcCtD
Celecoxib—Nausea—Irinotecan—stomach cancer	6.06e-05	0.000405	CcSEcCtD
Celecoxib—Immune system disorder—Epirubicin—stomach cancer	6.04e-05	0.000404	CcSEcCtD
Celecoxib—Mediastinal disorder—Epirubicin—stomach cancer	6.03e-05	0.000403	CcSEcCtD
Celecoxib—Constipation—Docetaxel—stomach cancer	6.03e-05	0.000403	CcSEcCtD
Celecoxib—Back pain—Methotrexate—stomach cancer	6.02e-05	0.000402	CcSEcCtD
Celecoxib—Dyspepsia—Capecitabine—stomach cancer	6.01e-05	0.000402	CcSEcCtD
Celecoxib—Arrhythmia—Epirubicin—stomach cancer	5.98e-05	0.0004	CcSEcCtD
Celecoxib—Decreased appetite—Capecitabine—stomach cancer	5.93e-05	0.000397	CcSEcCtD
Celecoxib—Alopecia—Epirubicin—stomach cancer	5.91e-05	0.000395	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Capecitabine—stomach cancer	5.89e-05	0.000394	CcSEcCtD
Celecoxib—Fatigue—Capecitabine—stomach cancer	5.88e-05	0.000393	CcSEcCtD
Celecoxib—Vision blurred—Methotrexate—stomach cancer	5.87e-05	0.000392	CcSEcCtD
Celecoxib—Mental disorder—Epirubicin—stomach cancer	5.86e-05	0.000392	CcSEcCtD
Celecoxib—Erythema multiforme—Doxorubicin—stomach cancer	5.85e-05	0.000391	CcSEcCtD
Celecoxib—Constipation—Capecitabine—stomach cancer	5.84e-05	0.00039	CcSEcCtD
Celecoxib—Feeling abnormal—Docetaxel—stomach cancer	5.81e-05	0.000388	CcSEcCtD
Celecoxib—Nausea—Fluorouracil—stomach cancer	5.8e-05	0.000388	CcSEcCtD
Celecoxib—Eye disorder—Doxorubicin—stomach cancer	5.79e-05	0.000387	CcSEcCtD
Celecoxib—Tinnitus—Doxorubicin—stomach cancer	5.77e-05	0.000386	CcSEcCtD
Celecoxib—Gastrointestinal pain—Docetaxel—stomach cancer	5.76e-05	0.000385	CcSEcCtD
Celecoxib—Anaemia—Methotrexate—stomach cancer	5.75e-05	0.000385	CcSEcCtD
Celecoxib—Flushing—Doxorubicin—stomach cancer	5.75e-05	0.000384	CcSEcCtD
Celecoxib—Cardiac disorder—Doxorubicin—stomach cancer	5.75e-05	0.000384	CcSEcCtD
Celecoxib—Flatulence—Epirubicin—stomach cancer	5.74e-05	0.000384	CcSEcCtD
Celecoxib—Tension—Epirubicin—stomach cancer	5.72e-05	0.000382	CcSEcCtD
Celecoxib—Dysgeusia—Epirubicin—stomach cancer	5.7e-05	0.000381	CcSEcCtD
Celecoxib—Nervousness—Epirubicin—stomach cancer	5.66e-05	0.000378	CcSEcCtD
Celecoxib—Back pain—Epirubicin—stomach cancer	5.63e-05	0.000377	CcSEcCtD
Celecoxib—Feeling abnormal—Capecitabine—stomach cancer	5.62e-05	0.000376	CcSEcCtD
Celecoxib—Angiopathy—Doxorubicin—stomach cancer	5.62e-05	0.000375	CcSEcCtD
Celecoxib—Muscle spasms—Epirubicin—stomach cancer	5.6e-05	0.000374	CcSEcCtD
Celecoxib—Immune system disorder—Doxorubicin—stomach cancer	5.59e-05	0.000374	CcSEcCtD
Celecoxib—Vertigo—Methotrexate—stomach cancer	5.59e-05	0.000374	CcSEcCtD
Celecoxib—Gastrointestinal pain—Capecitabine—stomach cancer	5.58e-05	0.000373	CcSEcCtD
Celecoxib—Mediastinal disorder—Doxorubicin—stomach cancer	5.58e-05	0.000373	CcSEcCtD
Celecoxib—Abdominal pain—Docetaxel—stomach cancer	5.57e-05	0.000372	CcSEcCtD
Celecoxib—Body temperature increased—Docetaxel—stomach cancer	5.57e-05	0.000372	CcSEcCtD
Celecoxib—Leukopenia—Methotrexate—stomach cancer	5.57e-05	0.000372	CcSEcCtD
Celecoxib—Arrhythmia—Doxorubicin—stomach cancer	5.53e-05	0.00037	CcSEcCtD
Celecoxib—Vision blurred—Epirubicin—stomach cancer	5.49e-05	0.000367	CcSEcCtD
Celecoxib—Alopecia—Doxorubicin—stomach cancer	5.47e-05	0.000366	CcSEcCtD
Celecoxib—Cough—Methotrexate—stomach cancer	5.43e-05	0.000363	CcSEcCtD
Celecoxib—Mental disorder—Doxorubicin—stomach cancer	5.42e-05	0.000363	CcSEcCtD
Celecoxib—Urticaria—Capecitabine—stomach cancer	5.42e-05	0.000362	CcSEcCtD
Celecoxib—Abdominal pain—Capecitabine—stomach cancer	5.39e-05	0.000361	CcSEcCtD
Celecoxib—Body temperature increased—Capecitabine—stomach cancer	5.39e-05	0.000361	CcSEcCtD
Celecoxib—Anaemia—Epirubicin—stomach cancer	5.38e-05	0.00036	CcSEcCtD
Celecoxib—Flatulence—Doxorubicin—stomach cancer	5.31e-05	0.000355	CcSEcCtD
Celecoxib—Myalgia—Methotrexate—stomach cancer	5.3e-05	0.000354	CcSEcCtD
Celecoxib—Arthralgia—Methotrexate—stomach cancer	5.3e-05	0.000354	CcSEcCtD
Celecoxib—Chest pain—Methotrexate—stomach cancer	5.3e-05	0.000354	CcSEcCtD
Celecoxib—Tension—Doxorubicin—stomach cancer	5.29e-05	0.000354	CcSEcCtD
Celecoxib—Dysgeusia—Doxorubicin—stomach cancer	5.28e-05	0.000353	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	5.26e-05	0.000352	CcSEcCtD
Celecoxib—Nervousness—Doxorubicin—stomach cancer	5.23e-05	0.00035	CcSEcCtD
Celecoxib—Vertigo—Epirubicin—stomach cancer	5.23e-05	0.00035	CcSEcCtD
Celecoxib—Syncope—Epirubicin—stomach cancer	5.22e-05	0.000349	CcSEcCtD
Celecoxib—Leukopenia—Epirubicin—stomach cancer	5.21e-05	0.000349	CcSEcCtD
Celecoxib—Back pain—Doxorubicin—stomach cancer	5.21e-05	0.000348	CcSEcCtD
Celecoxib—Hypersensitivity—Docetaxel—stomach cancer	5.19e-05	0.000347	CcSEcCtD
Celecoxib—Muscle spasms—Doxorubicin—stomach cancer	5.18e-05	0.000346	CcSEcCtD
Celecoxib—Palpitations—Epirubicin—stomach cancer	5.15e-05	0.000344	CcSEcCtD
Celecoxib—Confusional state—Methotrexate—stomach cancer	5.12e-05	0.000342	CcSEcCtD
Celecoxib—Loss of consciousness—Epirubicin—stomach cancer	5.12e-05	0.000342	CcSEcCtD
Celecoxib—Cough—Epirubicin—stomach cancer	5.08e-05	0.00034	CcSEcCtD
Celecoxib—Anaphylactic shock—Methotrexate—stomach cancer	5.08e-05	0.00034	CcSEcCtD
Celecoxib—Vision blurred—Doxorubicin—stomach cancer	5.08e-05	0.00034	CcSEcCtD
Celecoxib—Asthenia—Docetaxel—stomach cancer	5.06e-05	0.000338	CcSEcCtD
Celecoxib—Infection—Methotrexate—stomach cancer	5.05e-05	0.000337	CcSEcCtD
Celecoxib—Hypertension—Epirubicin—stomach cancer	5.03e-05	0.000336	CcSEcCtD
Celecoxib—Hypersensitivity—Capecitabine—stomach cancer	5.03e-05	0.000336	CcSEcCtD
Celecoxib—Pruritus—Docetaxel—stomach cancer	4.99e-05	0.000333	CcSEcCtD
Celecoxib—Nervous system disorder—Methotrexate—stomach cancer	4.98e-05	0.000333	CcSEcCtD
Celecoxib—Anaemia—Doxorubicin—stomach cancer	4.98e-05	0.000333	CcSEcCtD
Celecoxib—Thrombocytopenia—Methotrexate—stomach cancer	4.97e-05	0.000332	CcSEcCtD
Celecoxib—Chest pain—Epirubicin—stomach cancer	4.96e-05	0.000331	CcSEcCtD
Celecoxib—Arthralgia—Epirubicin—stomach cancer	4.96e-05	0.000331	CcSEcCtD
Celecoxib—Myalgia—Epirubicin—stomach cancer	4.96e-05	0.000331	CcSEcCtD
Celecoxib—Anxiety—Epirubicin—stomach cancer	4.94e-05	0.00033	CcSEcCtD
Celecoxib—Skin disorder—Methotrexate—stomach cancer	4.93e-05	0.00033	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	4.92e-05	0.000329	CcSEcCtD
Celecoxib—Hyperhidrosis—Methotrexate—stomach cancer	4.91e-05	0.000328	CcSEcCtD
Celecoxib—Asthenia—Capecitabine—stomach cancer	4.9e-05	0.000327	CcSEcCtD
Celecoxib—Dry mouth—Epirubicin—stomach cancer	4.85e-05	0.000324	CcSEcCtD
Celecoxib—Vertigo—Doxorubicin—stomach cancer	4.84e-05	0.000324	CcSEcCtD
Celecoxib—Anorexia—Methotrexate—stomach cancer	4.84e-05	0.000324	CcSEcCtD
Celecoxib—Syncope—Doxorubicin—stomach cancer	4.83e-05	0.000323	CcSEcCtD
Celecoxib—Pruritus—Capecitabine—stomach cancer	4.83e-05	0.000323	CcSEcCtD
Celecoxib—Leukopenia—Doxorubicin—stomach cancer	4.82e-05	0.000322	CcSEcCtD
Celecoxib—Diarrhoea—Docetaxel—stomach cancer	4.82e-05	0.000322	CcSEcCtD
Celecoxib—Confusional state—Epirubicin—stomach cancer	4.79e-05	0.00032	CcSEcCtD
Celecoxib—Palpitations—Doxorubicin—stomach cancer	4.76e-05	0.000318	CcSEcCtD
Celecoxib—Oedema—Epirubicin—stomach cancer	4.75e-05	0.000318	CcSEcCtD
Celecoxib—Anaphylactic shock—Epirubicin—stomach cancer	4.75e-05	0.000318	CcSEcCtD
Celecoxib—Loss of consciousness—Doxorubicin—stomach cancer	4.74e-05	0.000317	CcSEcCtD
Celecoxib—Infection—Epirubicin—stomach cancer	4.72e-05	0.000316	CcSEcCtD
Celecoxib—Cough—Doxorubicin—stomach cancer	4.7e-05	0.000314	CcSEcCtD
Celecoxib—Shock—Epirubicin—stomach cancer	4.68e-05	0.000313	CcSEcCtD
Celecoxib—Diarrhoea—Capecitabine—stomach cancer	4.67e-05	0.000312	CcSEcCtD
Celecoxib—Nervous system disorder—Epirubicin—stomach cancer	4.66e-05	0.000312	CcSEcCtD
Celecoxib—Dizziness—Docetaxel—stomach cancer	4.66e-05	0.000312	CcSEcCtD
Celecoxib—Thrombocytopenia—Epirubicin—stomach cancer	4.65e-05	0.000311	CcSEcCtD
Celecoxib—Hypertension—Doxorubicin—stomach cancer	4.65e-05	0.000311	CcSEcCtD
Celecoxib—Tachycardia—Epirubicin—stomach cancer	4.64e-05	0.00031	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.63e-05	0.000309	CcSEcCtD
Celecoxib—Skin disorder—Epirubicin—stomach cancer	4.62e-05	0.000309	CcSEcCtD
Celecoxib—Hyperhidrosis—Epirubicin—stomach cancer	4.6e-05	0.000307	CcSEcCtD
Celecoxib—Insomnia—Methotrexate—stomach cancer	4.59e-05	0.000307	CcSEcCtD
Celecoxib—Arthralgia—Doxorubicin—stomach cancer	4.59e-05	0.000307	CcSEcCtD
Celecoxib—Chest pain—Doxorubicin—stomach cancer	4.59e-05	0.000307	CcSEcCtD
Celecoxib—Myalgia—Doxorubicin—stomach cancer	4.59e-05	0.000307	CcSEcCtD
Celecoxib—Anxiety—Doxorubicin—stomach cancer	4.57e-05	0.000306	CcSEcCtD
Celecoxib—Paraesthesia—Methotrexate—stomach cancer	4.56e-05	0.000305	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	4.56e-05	0.000305	CcSEcCtD
Celecoxib—Anorexia—Epirubicin—stomach cancer	4.53e-05	0.000303	CcSEcCtD
Celecoxib—Dyspnoea—Methotrexate—stomach cancer	4.53e-05	0.000303	CcSEcCtD
Celecoxib—Somnolence—Methotrexate—stomach cancer	4.52e-05	0.000302	CcSEcCtD
Celecoxib—Dizziness—Capecitabine—stomach cancer	4.51e-05	0.000302	CcSEcCtD
Celecoxib—Dry mouth—Doxorubicin—stomach cancer	4.49e-05	0.0003	CcSEcCtD
Celecoxib—Vomiting—Docetaxel—stomach cancer	4.48e-05	0.0003	CcSEcCtD
Celecoxib—Dyspepsia—Methotrexate—stomach cancer	4.47e-05	0.000299	CcSEcCtD
Celecoxib—Rash—Docetaxel—stomach cancer	4.44e-05	0.000297	CcSEcCtD
Celecoxib—Dermatitis—Docetaxel—stomach cancer	4.44e-05	0.000297	CcSEcCtD
Celecoxib—Confusional state—Doxorubicin—stomach cancer	4.43e-05	0.000296	CcSEcCtD
Celecoxib—Decreased appetite—Methotrexate—stomach cancer	4.42e-05	0.000295	CcSEcCtD
Celecoxib—Headache—Docetaxel—stomach cancer	4.42e-05	0.000295	CcSEcCtD
Celecoxib—Oedema—Doxorubicin—stomach cancer	4.4e-05	0.000294	CcSEcCtD
Celecoxib—Anaphylactic shock—Doxorubicin—stomach cancer	4.4e-05	0.000294	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Methotrexate—stomach cancer	4.39e-05	0.000293	CcSEcCtD
Celecoxib—Fatigue—Methotrexate—stomach cancer	4.38e-05	0.000293	CcSEcCtD
Celecoxib—Infection—Doxorubicin—stomach cancer	4.37e-05	0.000292	CcSEcCtD
Celecoxib—Vomiting—Capecitabine—stomach cancer	4.34e-05	0.00029	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Epirubicin—stomach cancer	4.33e-05	0.00029	CcSEcCtD
Celecoxib—Shock—Doxorubicin—stomach cancer	4.33e-05	0.000289	CcSEcCtD
Celecoxib—Nervous system disorder—Doxorubicin—stomach cancer	4.31e-05	0.000288	CcSEcCtD
Celecoxib—Thrombocytopenia—Doxorubicin—stomach cancer	4.31e-05	0.000288	CcSEcCtD
Celecoxib—Rash—Capecitabine—stomach cancer	4.3e-05	0.000288	CcSEcCtD
Celecoxib—Insomnia—Epirubicin—stomach cancer	4.3e-05	0.000287	CcSEcCtD
Celecoxib—Dermatitis—Capecitabine—stomach cancer	4.3e-05	0.000287	CcSEcCtD
Celecoxib—Tachycardia—Doxorubicin—stomach cancer	4.29e-05	0.000287	CcSEcCtD
Celecoxib—Headache—Capecitabine—stomach cancer	4.27e-05	0.000286	CcSEcCtD
Celecoxib—Skin disorder—Doxorubicin—stomach cancer	4.27e-05	0.000286	CcSEcCtD
Celecoxib—Paraesthesia—Epirubicin—stomach cancer	4.27e-05	0.000285	CcSEcCtD
Celecoxib—Hyperhidrosis—Doxorubicin—stomach cancer	4.25e-05	0.000284	CcSEcCtD
Celecoxib—Dyspnoea—Epirubicin—stomach cancer	4.24e-05	0.000283	CcSEcCtD
Celecoxib—Somnolence—Epirubicin—stomach cancer	4.23e-05	0.000282	CcSEcCtD
Celecoxib—Anorexia—Doxorubicin—stomach cancer	4.19e-05	0.00028	CcSEcCtD
Celecoxib—Nausea—Docetaxel—stomach cancer	4.19e-05	0.00028	CcSEcCtD
Celecoxib—Feeling abnormal—Methotrexate—stomach cancer	4.19e-05	0.00028	CcSEcCtD
Celecoxib—Dyspepsia—Epirubicin—stomach cancer	4.18e-05	0.00028	CcSEcCtD
Celecoxib—Gastrointestinal pain—Methotrexate—stomach cancer	4.15e-05	0.000278	CcSEcCtD
Celecoxib—Decreased appetite—Epirubicin—stomach cancer	4.13e-05	0.000276	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Epirubicin—stomach cancer	4.1e-05	0.000274	CcSEcCtD
Celecoxib—Fatigue—Epirubicin—stomach cancer	4.1e-05	0.000274	CcSEcCtD
Celecoxib—Constipation—Epirubicin—stomach cancer	4.07e-05	0.000272	CcSEcCtD
Celecoxib—Nausea—Capecitabine—stomach cancer	4.05e-05	0.000271	CcSEcCtD
Celecoxib—Urticaria—Methotrexate—stomach cancer	4.04e-05	0.00027	CcSEcCtD
Celecoxib—Abdominal pain—Methotrexate—stomach cancer	4.02e-05	0.000268	CcSEcCtD
Celecoxib—Body temperature increased—Methotrexate—stomach cancer	4.02e-05	0.000268	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Doxorubicin—stomach cancer	4.01e-05	0.000268	CcSEcCtD
Celecoxib—Insomnia—Doxorubicin—stomach cancer	3.98e-05	0.000266	CcSEcCtD
Celecoxib—Paraesthesia—Doxorubicin—stomach cancer	3.95e-05	0.000264	CcSEcCtD
Celecoxib—Dyspnoea—Doxorubicin—stomach cancer	3.92e-05	0.000262	CcSEcCtD
Celecoxib—Feeling abnormal—Epirubicin—stomach cancer	3.92e-05	0.000262	CcSEcCtD
Celecoxib—Somnolence—Doxorubicin—stomach cancer	3.91e-05	0.000261	CcSEcCtD
Celecoxib—Gastrointestinal pain—Epirubicin—stomach cancer	3.89e-05	0.00026	CcSEcCtD
Celecoxib—Dyspepsia—Doxorubicin—stomach cancer	3.87e-05	0.000259	CcSEcCtD
Celecoxib—Decreased appetite—Doxorubicin—stomach cancer	3.82e-05	0.000256	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.8e-05	0.000254	CcSEcCtD
Celecoxib—Fatigue—Doxorubicin—stomach cancer	3.79e-05	0.000253	CcSEcCtD
Celecoxib—Urticaria—Epirubicin—stomach cancer	3.78e-05	0.000252	CcSEcCtD
Celecoxib—Constipation—Doxorubicin—stomach cancer	3.76e-05	0.000251	CcSEcCtD
Celecoxib—Body temperature increased—Epirubicin—stomach cancer	3.76e-05	0.000251	CcSEcCtD
Celecoxib—Abdominal pain—Epirubicin—stomach cancer	3.76e-05	0.000251	CcSEcCtD
Celecoxib—Hypersensitivity—Methotrexate—stomach cancer	3.74e-05	0.00025	CcSEcCtD
Celecoxib—Asthenia—Methotrexate—stomach cancer	3.64e-05	0.000244	CcSEcCtD
Celecoxib—Feeling abnormal—Doxorubicin—stomach cancer	3.62e-05	0.000242	CcSEcCtD
Celecoxib—Gastrointestinal pain—Doxorubicin—stomach cancer	3.6e-05	0.00024	CcSEcCtD
Celecoxib—Pruritus—Methotrexate—stomach cancer	3.59e-05	0.00024	CcSEcCtD
Celecoxib—Hypersensitivity—Epirubicin—stomach cancer	3.5e-05	0.000234	CcSEcCtD
Celecoxib—Urticaria—Doxorubicin—stomach cancer	3.49e-05	0.000234	CcSEcCtD
Celecoxib—Body temperature increased—Doxorubicin—stomach cancer	3.48e-05	0.000232	CcSEcCtD
Celecoxib—Abdominal pain—Doxorubicin—stomach cancer	3.48e-05	0.000232	CcSEcCtD
Celecoxib—Diarrhoea—Methotrexate—stomach cancer	3.48e-05	0.000232	CcSEcCtD
Celecoxib—Asthenia—Epirubicin—stomach cancer	3.41e-05	0.000228	CcSEcCtD
Celecoxib—Pruritus—Epirubicin—stomach cancer	3.36e-05	0.000225	CcSEcCtD
Celecoxib—Dizziness—Methotrexate—stomach cancer	3.36e-05	0.000225	CcSEcCtD
Celecoxib—Diarrhoea—Epirubicin—stomach cancer	3.25e-05	0.000217	CcSEcCtD
Celecoxib—Hypersensitivity—Doxorubicin—stomach cancer	3.24e-05	0.000217	CcSEcCtD
Celecoxib—Vomiting—Methotrexate—stomach cancer	3.23e-05	0.000216	CcSEcCtD
Celecoxib—Rash—Methotrexate—stomach cancer	3.2e-05	0.000214	CcSEcCtD
Celecoxib—Dermatitis—Methotrexate—stomach cancer	3.2e-05	0.000214	CcSEcCtD
Celecoxib—Headache—Methotrexate—stomach cancer	3.18e-05	0.000213	CcSEcCtD
Celecoxib—Asthenia—Doxorubicin—stomach cancer	3.16e-05	0.000211	CcSEcCtD
Celecoxib—Dizziness—Epirubicin—stomach cancer	3.14e-05	0.00021	CcSEcCtD
Celecoxib—Pruritus—Doxorubicin—stomach cancer	3.11e-05	0.000208	CcSEcCtD
Celecoxib—Vomiting—Epirubicin—stomach cancer	3.02e-05	0.000202	CcSEcCtD
Celecoxib—Nausea—Methotrexate—stomach cancer	3.02e-05	0.000202	CcSEcCtD
Celecoxib—Diarrhoea—Doxorubicin—stomach cancer	3.01e-05	0.000201	CcSEcCtD
Celecoxib—Rash—Epirubicin—stomach cancer	3e-05	0.0002	CcSEcCtD
Celecoxib—Dermatitis—Epirubicin—stomach cancer	2.99e-05	0.0002	CcSEcCtD
Celecoxib—Headache—Epirubicin—stomach cancer	2.98e-05	0.000199	CcSEcCtD
Celecoxib—Dizziness—Doxorubicin—stomach cancer	2.91e-05	0.000194	CcSEcCtD
Celecoxib—Nausea—Epirubicin—stomach cancer	2.82e-05	0.000189	CcSEcCtD
Celecoxib—Vomiting—Doxorubicin—stomach cancer	2.8e-05	0.000187	CcSEcCtD
Celecoxib—Rash—Doxorubicin—stomach cancer	2.77e-05	0.000185	CcSEcCtD
Celecoxib—Dermatitis—Doxorubicin—stomach cancer	2.77e-05	0.000185	CcSEcCtD
Celecoxib—Headache—Doxorubicin—stomach cancer	2.76e-05	0.000184	CcSEcCtD
Celecoxib—Nausea—Doxorubicin—stomach cancer	2.61e-05	0.000175	CcSEcCtD
Celecoxib—CYP3A4—Metabolism—NDUFA2—stomach cancer	4.29e-06	2.67e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CKB—stomach cancer	4.29e-06	2.67e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CA1—stomach cancer	4.29e-06	2.67e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—RORA—stomach cancer	4.29e-06	2.67e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HRAS—stomach cancer	4.28e-06	2.67e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—KRAS—stomach cancer	4.25e-06	2.65e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—PIK3CA—stomach cancer	4.23e-06	2.63e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SMAD4—stomach cancer	4.22e-06	2.63e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CDKN1B—stomach cancer	4.21e-06	2.62e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	4.2e-06	2.62e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—PIK3CA—stomach cancer	4.19e-06	2.61e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PPP2R1A—stomach cancer	4.14e-06	2.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—KRAS—stomach cancer	4.11e-06	2.56e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—stomach cancer	4.1e-06	2.55e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CD44—stomach cancer	4.08e-06	2.54e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.07e-06	2.54e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SERPINE1—stomach cancer	4.07e-06	2.53e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALDOB—stomach cancer	4.06e-06	2.53e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—stomach cancer	4.05e-06	2.52e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLIN2—stomach cancer	4.04e-06	2.51e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SERPINE1—stomach cancer	4.03e-06	2.51e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALDOB—stomach cancer	4.02e-06	2.51e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCND1—stomach cancer	4.01e-06	2.5e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—JUN—stomach cancer	4.01e-06	2.5e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FYN—stomach cancer	4e-06	2.49e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTT1—stomach cancer	3.97e-06	2.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—HRAS—stomach cancer	3.95e-06	2.46e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP2A6—stomach cancer	3.93e-06	2.45e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CA2—stomach cancer	3.93e-06	2.45e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HRAS—stomach cancer	3.91e-06	2.44e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PIK3CA—stomach cancer	3.9e-06	2.43e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—stomach cancer	3.9e-06	2.43e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—RHOA—stomach cancer	3.89e-06	2.42e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CDKN1A—stomach cancer	3.88e-06	2.42e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HRAS—stomach cancer	3.88e-06	2.41e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SMAD4—stomach cancer	3.85e-06	2.4e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS3—stomach cancer	3.85e-06	2.4e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PGAM1—stomach cancer	3.83e-06	2.38e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NT5E—stomach cancer	3.83e-06	2.38e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKR1C3—stomach cancer	3.82e-06	2.38e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.79e-06	2.36e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK8—stomach cancer	3.79e-06	2.36e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.78e-06	2.36e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—stomach cancer	3.78e-06	2.36e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PIK3CA—stomach cancer	3.77e-06	2.35e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALOX5—stomach cancer	3.77e-06	2.35e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FGFR2—stomach cancer	3.76e-06	2.34e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—stomach cancer	3.74e-06	2.33e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALOX5—stomach cancer	3.74e-06	2.33e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ENO1—stomach cancer	3.72e-06	2.32e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—DPYD—stomach cancer	3.71e-06	2.31e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—DPYD—stomach cancer	3.68e-06	2.29e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FYN—stomach cancer	3.65e-06	2.28e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ERBB2—stomach cancer	3.65e-06	2.27e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLCE1—stomach cancer	3.65e-06	2.27e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALDH7A1—stomach cancer	3.65e-06	2.27e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HRAS—stomach cancer	3.61e-06	2.25e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ERCC2—stomach cancer	3.51e-06	2.19e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—UMPS—stomach cancer	3.5e-06	2.18e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—stomach cancer	3.5e-06	2.18e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HRAS—stomach cancer	3.49e-06	2.17e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PIK3CA—stomach cancer	3.48e-06	2.17e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPP2R1A—stomach cancer	3.47e-06	2.16e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—STAT3—stomach cancer	3.46e-06	2.16e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—stomach cancer	3.46e-06	2.15e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IRS2—stomach cancer	3.44e-06	2.14e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FGFR2—stomach cancer	3.43e-06	2.14e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTP1—stomach cancer	3.4e-06	2.12e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDKN1B—stomach cancer	3.38e-06	2.11e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HMOX1—stomach cancer	3.36e-06	2.09e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PIK3CA—stomach cancer	3.34e-06	2.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—stomach cancer	3.34e-06	2.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CAV1—stomach cancer	3.34e-06	2.08e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.33e-06	2.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOA1—stomach cancer	3.33e-06	2.07e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—stomach cancer	3.32e-06	2.07e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK3—stomach cancer	3.31e-06	2.06e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CD44—stomach cancer	3.3e-06	2.06e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTHFR—stomach cancer	3.3e-06	2.06e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTT1—stomach cancer	3.28e-06	2.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PDHA1—stomach cancer	3.25e-06	2.03e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ECHS1—stomach cancer	3.25e-06	2.03e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTT1—stomach cancer	3.25e-06	2.03e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP2A6—stomach cancer	3.24e-06	2.02e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MYC—stomach cancer	3.22e-06	2.01e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—JUN—stomach cancer	3.22e-06	2.01e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP2A6—stomach cancer	3.21e-06	2e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.2e-06	2e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRKCB—stomach cancer	3.18e-06	1.98e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TYMS—stomach cancer	3.16e-06	1.97e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6ST—stomach cancer	3.16e-06	1.97e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKR1C3—stomach cancer	3.15e-06	1.97e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK1—stomach cancer	3.15e-06	1.96e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—stomach cancer	3.15e-06	1.96e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IRS2—stomach cancer	3.14e-06	1.96e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTM1—stomach cancer	3.13e-06	1.95e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKR1C3—stomach cancer	3.13e-06	1.95e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDKN1A—stomach cancer	3.12e-06	1.94e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ENO1—stomach cancer	3.07e-06	1.92e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TYMP—stomach cancer	3.06e-06	1.91e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—FADS1—stomach cancer	3.06e-06	1.91e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ENO1—stomach cancer	3.05e-06	1.9e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK8—stomach cancer	3.05e-06	1.9e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CAV1—stomach cancer	3.05e-06	1.9e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APC—stomach cancer	3.04e-06	1.89e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOA1—stomach cancer	3.04e-06	1.89e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3e-06	1.87e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KRAS—stomach cancer	2.97e-06	1.85e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ERCC2—stomach cancer	2.94e-06	1.83e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6ST—stomach cancer	2.89e-06	1.8e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SREBF2—stomach cancer	2.86e-06	1.78e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—RORA—stomach cancer	2.83e-06	1.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6R—stomach cancer	2.82e-06	1.76e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PIK3CA—stomach cancer	2.81e-06	1.75e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPP2R1A—stomach cancer	2.81e-06	1.75e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—STAT3—stomach cancer	2.78e-06	1.73e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APC—stomach cancer	2.77e-06	1.73e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—stomach cancer	2.77e-06	1.73e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—stomach cancer	2.76e-06	1.72e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTP1—stomach cancer	2.75e-06	1.72e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PIK3CA—stomach cancer	2.73e-06	1.7e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CD44—stomach cancer	2.73e-06	1.7e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMOX1—stomach cancer	2.72e-06	1.69e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CD44—stomach cancer	2.7e-06	1.68e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK3—stomach cancer	2.66e-06	1.66e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALDOB—stomach cancer	2.65e-06	1.65e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MAPK3—stomach cancer	2.65e-06	1.65e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—stomach cancer	2.64e-06	1.65e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SERPINE1—stomach cancer	2.64e-06	1.65e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.62e-06	1.63e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MAPK3—stomach cancer	2.62e-06	1.63e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6R—stomach cancer	2.58e-06	1.6e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MYC—stomach cancer	2.57e-06	1.6e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TYMS—stomach cancer	2.56e-06	1.6e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CAV1—stomach cancer	2.55e-06	1.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RHOA—stomach cancer	2.55e-06	1.59e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOA1—stomach cancer	2.54e-06	1.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK1—stomach cancer	2.53e-06	1.58e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTM1—stomach cancer	2.53e-06	1.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—stomach cancer	2.53e-06	1.58e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRAS—stomach cancer	2.53e-06	1.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—stomach cancer	2.52e-06	1.57e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MAPK1—stomach cancer	2.5e-06	1.55e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALOX5—stomach cancer	2.47e-06	1.54e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.44e-06	1.52e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DPYD—stomach cancer	2.43e-06	1.51e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—stomach cancer	2.42e-06	1.51e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SERPINE1—stomach cancer	2.41e-06	1.5e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KRAS—stomach cancer	2.39e-06	1.49e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ERCC2—stomach cancer	2.38e-06	1.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ERBB2—stomach cancer	2.36e-06	1.47e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—KRAS—stomach cancer	2.36e-06	1.47e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—RHOA—stomach cancer	2.33e-06	1.45e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPP2R1A—stomach cancer	2.32e-06	1.44e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—stomach cancer	2.3e-06	1.43e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPP2R1A—stomach cancer	2.3e-06	1.43e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTP1—stomach cancer	2.27e-06	1.42e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTP1—stomach cancer	2.25e-06	1.4e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMOX1—stomach cancer	2.24e-06	1.4e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARG—stomach cancer	2.24e-06	1.4e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL8—stomach cancer	2.24e-06	1.39e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—stomach cancer	2.24e-06	1.39e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMOX1—stomach cancer	2.22e-06	1.39e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PIK3CA—stomach cancer	2.2e-06	1.37e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDKN1B—stomach cancer	2.19e-06	1.36e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PIK3CA—stomach cancer	2.17e-06	1.35e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ERBB2—stomach cancer	2.15e-06	1.34e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTT1—stomach cancer	2.14e-06	1.34e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP2A6—stomach cancer	2.12e-06	1.32e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TYMS—stomach cancer	2.11e-06	1.32e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TYMS—stomach cancer	2.1e-06	1.31e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—stomach cancer	2.09e-06	1.3e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTM1—stomach cancer	2.09e-06	1.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCND1—stomach cancer	2.09e-06	1.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JUN—stomach cancer	2.08e-06	1.3e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTM1—stomach cancer	2.07e-06	1.29e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CAV1—stomach cancer	2.06e-06	1.29e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.06e-06	1.28e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOA1—stomach cancer	2.06e-06	1.28e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HRAS—stomach cancer	2.03e-06	1.27e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—stomach cancer	2.02e-06	1.26e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDKN1A—stomach cancer	2.02e-06	1.26e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—stomach cancer	2.02e-06	1.26e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ENO1—stomach cancer	2.01e-06	1.25e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HRAS—stomach cancer	2e-06	1.25e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDKN1B—stomach cancer	1.99e-06	1.24e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.97e-06	1.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK8—stomach cancer	1.97e-06	1.23e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ERCC2—stomach cancer	1.96e-06	1.22e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ERCC2—stomach cancer	1.95e-06	1.21e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—stomach cancer	1.95e-06	1.21e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—stomach cancer	1.93e-06	1.2e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—stomach cancer	1.85e-06	1.15e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDKN1A—stomach cancer	1.84e-06	1.15e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—stomach cancer	1.83e-06	1.14e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—stomach cancer	1.82e-06	1.13e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARG—stomach cancer	1.81e-06	1.13e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STAT3—stomach cancer	1.8e-06	1.12e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CD44—stomach cancer	1.78e-06	1.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK3—stomach cancer	1.72e-06	1.07e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CAV1—stomach cancer	1.7e-06	1.06e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOA1—stomach cancer	1.7e-06	1.06e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CAV1—stomach cancer	1.69e-06	1.05e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOA1—stomach cancer	1.68e-06	1.05e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MYC—stomach cancer	1.67e-06	1.04e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—STAT3—stomach cancer	1.64e-06	1.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK1—stomach cancer	1.64e-06	1.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—stomach cancer	1.64e-06	1.02e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.61e-06	1.01e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAPK3—stomach cancer	1.57e-06	9.78e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—stomach cancer	1.56e-06	9.72e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KRAS—stomach cancer	1.55e-06	9.63e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MYC—stomach cancer	1.53e-06	9.51e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.52e-06	9.44e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARG—stomach cancer	1.5e-06	9.33e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAPK1—stomach cancer	1.49e-06	9.3e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—stomach cancer	1.49e-06	9.3e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTP1—stomach cancer	1.49e-06	9.26e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARG—stomach cancer	1.48e-06	9.25e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMOX1—stomach cancer	1.47e-06	9.14e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—stomach cancer	1.43e-06	8.89e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PIK3CA—stomach cancer	1.42e-06	8.85e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KRAS—stomach cancer	1.41e-06	8.79e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TYMS—stomach cancer	1.38e-06	8.61e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—stomach cancer	1.37e-06	8.56e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTM1—stomach cancer	1.37e-06	8.51e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—stomach cancer	1.35e-06	8.39e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—stomach cancer	1.33e-06	8.32e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRAS—stomach cancer	1.31e-06	8.19e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PIK3CA—stomach cancer	1.3e-06	8.07e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—stomach cancer	1.29e-06	8.03e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ERCC2—stomach cancer	1.28e-06	8e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—stomach cancer	1.28e-06	7.96e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—stomach cancer	1.26e-06	7.84e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—stomach cancer	1.21e-06	7.52e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HRAS—stomach cancer	1.2e-06	7.47e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—stomach cancer	1.18e-06	7.34e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—stomach cancer	1.17e-06	7.28e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—stomach cancer	1.15e-06	7.15e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CAV1—stomach cancer	1.11e-06	6.94e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOA1—stomach cancer	1.11e-06	6.92e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3CA—stomach cancer	1.09e-06	6.76e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARG—stomach cancer	9.79e-07	6.1e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—stomach cancer	8.8e-07	5.49e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3CA—stomach cancer	8.78e-07	5.47e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—stomach cancer	8.42e-07	5.25e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—stomach cancer	7.7e-07	4.8e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3CA—stomach cancer	7.25e-07	4.52e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3CA—stomach cancer	7.19e-07	4.48e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3CA—stomach cancer	4.74e-07	2.95e-06	CbGpPWpGaD
